157 related articles for article (PubMed ID: 15670952)
1. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
Yuan H; Parrill A
J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
[TBL] [Abstract][Full Text] [Related]
2. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
[TBL] [Abstract][Full Text] [Related]
3. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
Iyer M; Hopfinger AJ
J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
[TBL] [Abstract][Full Text] [Related]
4. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
[TBL] [Abstract][Full Text] [Related]
5. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
6. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
7. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
de Melo EB; Ferreira MM
Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
[TBL] [Abstract][Full Text] [Related]
8. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
Gupta P; Roy N; Garg P
Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
Gupta P; Garg P; Roy N
Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors.
Saíz-Urra L; González MP; Fall Y; Gómez G
Eur J Med Chem; 2007 Jan; 42(1):64-70. PubMed ID: 17030481
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
Nunthaboot N; Tonmunphean S; Parasuk V; Wolschann P; Kokpol S
Eur J Med Chem; 2006 Dec; 41(12):1359-72. PubMed ID: 17002889
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
[TBL] [Abstract][Full Text] [Related]
13. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
14. QSAR studies of HIV-1 integrase inhibition.
Yuan H; Parrill AL
Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
Dessalew N
Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
[TBL] [Abstract][Full Text] [Related]
16. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
[TBL] [Abstract][Full Text] [Related]
18. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
Cheng Z; Zhang Y; Fu W
Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors.
Shaikh AR; Ismael M; Del Carpio CA; Tsuboi H; Koyama M; Endou A; Kubo M; Broclawik E; Miyamoto A
Bioorg Med Chem Lett; 2006 Nov; 16(22):5917-25. PubMed ID: 16989998
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
